STOCK TITAN

PACS Group (PACS) details RSU grants to chief accounting officer

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PACS Group, Inc. reported an insider equity award for its Chief Accounting Officer on December 17, 2025. The officer acquired 32,500 shares of common stock tied to restricted stock units (RSUs) at a price of $0 and an additional 19,127 shares tied to RSUs, also at $0, as part of equity compensation.

The first RSU grant of 32,500 units will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to continued service. The second RSU grant of 19,127 units will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, also subject to the officer remaining in service. Following these transactions, the officer beneficially owns 378,218 shares of common stock directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lewis Michelle Renee

(Last) (First) (Middle)
C/O PACS GROUP, INC.
90 S. 400 W. SUITE 700

(Street)
SALT LAKE CITY UT 84101

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/17/2025 A 32,500(1) A $0 359,091 D
Common Stock 12/17/2025 A 19,127(2) A $0 378,218 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to the Reporting Person's continued service through the applicable vesting date.
2. Represents RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, subject to the Reporting Person's continued service through the applicable vesting date.
Remarks:
/s/ John Mitchell, Attorney-in-Fact 12/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PACS Group (PACS) report in this Form 4?

The filing shows the Chief Accounting Officer of PACS Group, Inc. acquired 32,500 and 19,127 shares of common stock on December 17, 2025 through restricted stock unit (RSU) awards at a price of $0 per share.

Who is the reporting person in the PACS Group (PACS) Form 4 and what is their role?

The reporting person is an officer of PACS Group, Inc. serving as the Chief Accounting Officer, as indicated in the relationship section of the filing.

How many PACS Group (PACS) RSUs were granted and at what price?

The officer received 32,500 RSU-linked shares and 19,127 RSU-linked shares of common stock, each reported at a price of $0 per share as equity awards.

What are the vesting terms of the 32,500 PACS Group (PACS) RSUs?

The 32,500 RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to the officer’s continued service through each vesting date.

What are the vesting terms of the 19,127 PACS Group (PACS) RSUs?

The 19,127 RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, conditioned on the officer’s continued service through each vesting date.

How many PACS Group (PACS) shares does the officer beneficially own after these transactions?

After the reported transactions, the filing shows the officer beneficially owns 378,218 shares of common stock directly.

Does this PACS Group (PACS) Form 4 involve any derivative securities?

The Table II section for derivative securities is present but does not list any specific derivative transactions; the reported activity relates to common stock and RSU-based awards.
PACS Group

NYSE:PACS

PACS Rankings

PACS Latest News

PACS Latest SEC Filings

PACS Stock Data

5.54B
44.82M
72.29%
29.09%
1.67%
Medical Care Facilities
Services-skilled Nursing Care Facilities
Link
United States
FARMINGTON